RT Journal Article
SR Electronic
T1 Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004427
DO 10.1136/jitc-2021-004427
VO 10
IS 5
A1 Qu, Yuan-Yuan
A1 Sun, Zhongquan
A1 Han, Weiqing
A1 Zou, Qing
A1 Xing, Nianzeng
A1 Luo, Hong
A1 Zhang, Xuepei
A1 He, Chaohong
A1 Bian, Xiao-Jie
A1 Cai, Jinling
A1 Chen, Chunxia
A1 Wang, Quanren
A1 Ye, Ding-Wei
YR 2022
UL http://jitc.bmj.com/content/10/5/e004427.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.